α-synuclein over expression, NRF2 suppression, and enhanced ferroptosis creates a vicious cycle of neuronal loss in Parkinson's disease
Annadurai AnandhaniD, W Chen, Lan Ngoc-NguyeniD, Lalitha MadhavaniD, Matthew B. DodsoniD, D.D. Zhang
Abstract
Parkinsons disease (PD) is the second most common neurodegenerative disorder, affecting millions each year. Most PD cases ([~]90%) are sporadic, resulting from the age-dependent accumulation of pathogenic effects. One key pathological hallmark of PD progression is the accumulation of alpha-synuclein (-syn), which has been shown to negatively affect neuronal function and viability. Here, using 3- and 6-month-old Nrf2+/+ and Nrf2-/- mice overexpressing human -syn (PD model), we show that loss of NRF2 increases markers of ferroptosis across PD-relevant brain regions. Increased ferroptosis was associated with an age- and genotype-dependent increase in -syn pathology and behavioral deficits. Finally, we demonstrate that -syn overexpression sensitizes neuronal cells and ex vivo brain slices to ferroptosis induction, which may be due to -syn suppression of NRF2 at the protein level. Altogether, these results indicate that NRF2 is a critical anti-ferroptotic mediator of neuronal survival, and that the vicious cycle of -syn overexpression and NRF2 suppression, leading to enhanced neuronal ferroptotic cell death, could represent a targetable and currently untapped means of preventing PD onset and progression.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 48
- FWCI
- 5.66
- Field percentile
- top 3%
- Organism
- Approach
Abstract summary
Claude Opus 5.5 · xhigh effort · 2 Nov 2026 · from the abstract
In Parkinson's disease models, alpha-synuclein overexpression sensitizes neurons to ferroptosis, potentially by suppressing NRF2 protein, while Nrf2 loss increases ferroptosis markers, alpha-synuclein pathology, and behavioral deficits.
Roughly 90% of Parkinson's disease (PD) cases are sporadic and characterized by age-dependent pathogenic accumulation of alpha-synuclein that impairs neuronal viability. By studying mice overexpressing human alpha-synuclein alongside neuronal cells and ex vivo brain slices, this work identifies a self-reinforcing loop linking alpha-synuclein accumulation, NRF2 suppression, and ferroptotic neuronal death.
Key results
ShownGenetic loss of Nrf2 elevates ferroptosis markers across PD-relevant brain regions and worsens alpha-synuclein pathology and behavioral deficits in an age- and genotype-dependent manner.
Shown in 3- and 6-month-old Nrf2+/+ and Nrf2-/- mice overexpressing human alpha-synuclein (no specific animal counts or effect sizes are reported in the abstract). · Abstract
ShownOverexpression of alpha-synuclein increases susceptibility to ferroptosis induction in neuronal cells and ex vivo brain slices, potentially via protein-level NRF2 suppression.
Demonstrated in neuronal cells and ex vivo brain slices overexpressing alpha-synuclein (no numerical measurements are provided in the abstract). · Abstract
Methods, data and reproducibility
The authors evaluated ferroptosis markers, alpha-synuclein pathology, and behavioral deficits across PD-relevant brain regions in 3- and 6-month-old Nrf2+/+ and Nrf2-/- mice overexpressing human alpha-synuclein. They also tested susceptibility to ferroptosis induction and NRF2 protein suppression upon alpha-synuclein overexpression in neuronal cells and ex vivo brain slices.
- 3- and 6-month-old Nrf2+/+ and Nrf2-/- mice overexpressing human alpha-synuclein · mouse (expressing human alpha-synuclein)
- Neuronal cells and ex vivo brain slices overexpressing alpha-synuclein
- Reproducibility gaps
- Sample sizes, specific ferroptosis markers, behavioral assay names, and data repositories are not stated in the abstract.
Limitations (2)
- All reported findings rely on Nrf2+/+ and Nrf2-/- mice, ex vivo brain slices, and neuronal cells overexpressing alpha-synuclein, without direct validation in human Parkinson's disease patient tissue. · noted in this summary
- Whether targeting the alpha-synuclein–NRF2–ferroptosis loop prevents Parkinson's disease onset or progression is proposed as a therapeutic concept rather than tested with an intervention in the abstract. · noted in this summary
Who should read:Read this if you study neurodegeneration or Parkinson's disease mechanisms and want evidence linking alpha-synuclein toxicity to NRF2 suppression and ferroptotic cell death.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
Alberto Delaidelli, Mette Richner, … Asad Jan·Acta Neuropathologica CommunicationsPeer-reviewed·Jun 6, 2021
- Alpha-synuclein and neuromelanin converge to promote Parkinsons disease pathology
Alba Nicolau, Marta González-Sepúlveda, … Miquel Vila·bioRxiv·Oct 24, 2026
- LRRK2 modifies α-syn pathology and spread in mouse models and human neurons
Gregor Bieri, Michel Brahic, … Aaron D. Gitler·Acta NeuropathologicaPeer-reviewed·Mar 29, 2019
- Nicotine Ameliorates α-synuclein Pre-formed Fibril-Induced Behavioral Deficits and Pathological Features in Mice
Zhangqiong Huang, Yue Pan, … Ying Guan·Applied Biochemistry and BiotechnologyPeer-reviewed·Jan 16, 2025
- The SNCA A53T mutation sensitizes human neurons and microglia to ferroptosis
Laura Mahoney‐Sanchez, Hannah J Lucas-Clarke, … Sonia Gandhi·bioRxiv·Oct 13, 2025
- Long-term exposure to PFE-360 in the AAV-α-synuclein rat model: findings and implications
Michael Aagaard Andersen, Florence Sotty, … Kenneth Vielsted Christensen·eNeuroPeer-reviewed·Nov 1, 2019